- 积分
- 1184
- 威望
- 1184
- 包包
- 1887
|
1. A Therapeutic OX40 Agonist Dynamically Alters Dendritic, Endothelial, and T Cell Subsets within the Established Tumor Microenvironment/ L$ C& f( }, ^* s3 ?: f f# O- R
. E* t3 D7 V- i" |2 [/ P
5 G+ E/ u& W# z9 E: K0 U9 \l2. Analysis of the T-Cell Receptor Repertoires of Tumor-Infiltrating Conventional and Regulatory T Cells Reveals No Evidence for Conversion in Carcinogen-Induced Tumors
" y- z) O- P& d
0 q9 t: X3 n5 i( A0 o
g1 Z+ J. p2 i( s: ^$ t/ L8 f
* l( W$ N- e1 p1 _3. A High Molecular Weight Melanoma-Associated Antigen–Specific Chimeric Antigen Receptor Redirects Lymphocytes to Target Human Melanomas. P6 x. O' c# y) f0 d# B. ]0 N7 {( X
$ {( g* v1 a6 [: V; A9 w6 I& t _8 p' x2 Q; T0 b1 |
4. Minimal Engagement of CD103 on Cytotoxic T Lymphocytes with an E-Cadherin-Fc Molecule Triggers Lytic Granule Polarization via a Phospholipase Cγ–Dependent Pathway
6 S0 {4 L- S2 r9 m& r8 m3 f; z) j! B, L9 u+ o& L. e
' ?. G0 p' ~4 }) Q! g9 I$ g5. Conditional Regulatory T-Cell Depletion Releases Adaptive Immunity Preventing Carcinogenesis and Suppressing Established Tumor Growth . O; e7 u! L; U3 B& ~
0 i! h4 ~# u7 [: t! r1 G |
附件: 你需要登录才可以下载或查看附件。没有帐号?注册
-
总评分: 威望 + 10
包包 + 25
查看全部评分
|